disclosure violations

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

Class action lawsuit filed against Regencell Bioscience for alleged false statements about market manipulation vulnerability and regulatory risks. Lead plaintiff deadline: June 23, 2026.

Class action lawsuit filed against Regencell Bioscience for alleged false statements regarding market manipulation vulnerability and regulatory exposure. Lead plaintiff deadline: June 23, 2026.

Schall Law Firm investigates Hycroft Mining ($HYMC) for alleged securities violations involving false statements and material disclosure failures. Shareholders with losses may participate.

SES AI Corporation faces securities fraud lawsuit alleging revenue inflation through related-party transactions and undisclosed logistics constraints, with stock down 37%.

Class action lawsuit filed against $FSK alleging false statements on portfolio restructuring, valuations, and distribution strategy from May 2024 to February 2026.

Lawsuit filed against $UHG alleging materially false statements regarding controlling shareholder's plans to force company sale and devalue assets.

Soleno Therapeutics faces class action lawsuit alleging false statements about DCCR drug safety. Lead plaintiff deadline: May 5, 2026.

Rosen Law Firm files class action against $ZSPC over alleged false statements in December 2024 IPO registration. Lead plaintiff deadline set for June 22, 2026.

Rosen Law Firm filed a class action against zSpace Inc. ($ZSPC) over alleged IPO disclosure failures regarding preferred shareholders and litigation risks. Lead plaintiff deadline is June 22, 2026.

Class action lawsuit filed against $UHG alleging false statements and nondisclosure regarding controlling shareholder's plan to force company sale and devalue stock.

Schall Law Firm investigates Empro Group Inc. ($EMPG) for alleged securities violations, false statements, and material nondisclosure. Firm seeks affected shareholders for class-action participation.

The Schall Law Firm is investigating $EPSM for potential securities fraud, including false statements and failure to disclose material information to shareholders.

Schall Law Firm investigates Diginex Limited for alleged false statements and material disclosure failures. Firm seeks affected shareholders who suffered losses.

Schall Law Firm investigates $CURX for potential securities fraud, alleging false statements and material disclosure failures. Harmed shareholders invited to participate.

Aldeyra Therapeutics faces federal securities lawsuit alleging inadequate disclosure of failed clinical trial results for reproxalap. Stock crashed 71% after FDA rejection; investor deadline May 29, 2026.

Apollo Global Management faces securities lawsuit over alleged false statements regarding executive ties to Jeffrey Epstein. Lead plaintiff deadline: May 1, 2026.

The Schall Law Firm is investigating Perimeter Solutions for potential securities fraud, claiming the company made false statements or failed to disclose material information to investors.

Law firm launches investigation into Kairos Pharma for potential securities violations involving false statements and material disclosure failures.